Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arpita Gandhi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|August 6, 2017
Olaratumab: A Novel Platelet-Derived Growth Factor Receptor α-Inhibitor for Advanced Soft Tissue SarcomaBenjamin J Andrick, Arpita Gandhi
Clinical Lymphoma, Myeloma & Leukemia|October 3, 2022
Oral Antineoplastics in Acute Myeloid Leukemia: A Comprehensive ReviewArpita Gandhi, Benjamin Andrick, Julianne Darling, et al.
Journal of the Advanced Practitioner in Oncology|March 17, 2022
Premedications for Cancer Therapies: A Primer for the Hematology/Oncology ProviderAmber Clemmons, Arpita Gandhi, Andrea Clarke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 16, 2018
Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O TrialAmber B Clemmons, Julianne Orr, Benjamin Andrick, et al.
Prehospital and Disaster Medicine|August 9, 2006
Disaster management following the Chi-Chi earthquake in TaiwanYu-Feng Chan, Kumar Alagappan, Arpita Gandhi, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|May 27, 2026
State Policy Variation and Telehealth Use by Oncology Specialists Treating Medicaid PatientsAnushree Vichare, Mandar Bodas, Qian Eric Luo, et al.
Hematology Reports|June 19, 2019
Availability of all-trans retinoic acid and support systems for management of acute promyelocytic leukemia in Michigan and Louisiana, USASheldon L Bolds, Shruthi M K Hassan, Catherine R Caprara, et al.
Cytotherapy|February 20, 2026
Impact of ABO compatibility on outcomes after allogeneic hematopoietic cell transplantation (HCT): increased risk of acute GVHD with ABO bidirectional mismatch, independent of traditional and emerging GVHD prophylaxis strategiesYun Yu, Mikayla K Murphy, Virginia Tan, et al.
Blood|March 5, 2026
Nonmyeloablative Conditioning Combined with Anti-CD117 Antibody Briquilimab in Older Adults with High-Risk AML and MDSLori S Muffly, Catherine J Lee, Arpita Gandhi, et al.
Blood Advances|November 28, 2022
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemiaCurtis A Lachowiez, Nicola Long, Jennifer Saultz, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|August 6, 2017
Olaratumab: A Novel Platelet-Derived Growth Factor Receptor α-Inhibitor for Advanced Soft Tissue SarcomaBenjamin J Andrick, Arpita Gandhi
Clinical Lymphoma, Myeloma & Leukemia|October 3, 2022
Oral Antineoplastics in Acute Myeloid Leukemia: A Comprehensive ReviewArpita Gandhi, Benjamin Andrick, Julianne Darling, et al.
Journal of the Advanced Practitioner in Oncology|March 17, 2022
Premedications for Cancer Therapies: A Primer for the Hematology/Oncology ProviderAmber Clemmons, Arpita Gandhi, Andrea Clarke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 16, 2018
Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O TrialAmber B Clemmons, Julianne Orr, Benjamin Andrick, et al.
Prehospital and Disaster Medicine|August 9, 2006
Disaster management following the Chi-Chi earthquake in TaiwanYu-Feng Chan, Kumar Alagappan, Arpita Gandhi, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|May 27, 2026
State Policy Variation and Telehealth Use by Oncology Specialists Treating Medicaid PatientsAnushree Vichare, Mandar Bodas, Qian Eric Luo, et al.
Hematology Reports|June 19, 2019
Availability of all-trans retinoic acid and support systems for management of acute promyelocytic leukemia in Michigan and Louisiana, USASheldon L Bolds, Shruthi M K Hassan, Catherine R Caprara, et al.
Cytotherapy|February 20, 2026
Impact of ABO compatibility on outcomes after allogeneic hematopoietic cell transplantation (HCT): increased risk of acute GVHD with ABO bidirectional mismatch, independent of traditional and emerging GVHD prophylaxis strategiesYun Yu, Mikayla K Murphy, Virginia Tan, et al.
Blood|March 5, 2026
Nonmyeloablative Conditioning Combined with Anti-CD117 Antibody Briquilimab in Older Adults with High-Risk AML and MDSLori S Muffly, Catherine J Lee, Arpita Gandhi, et al.
Blood Advances|November 28, 2022
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemiaCurtis A Lachowiez, Nicola Long, Jennifer Saultz, et al.
Pageof 2